Frank Magliochetti was born September 13, 1957 in Malden, Massachusetts. He attended Malden Catholic High School and was a four letter athlete for the school. After high-school he obtained a B.S. in Pharmacy from Northeastern University and played Baseball and football. He stayed at Northeastern and entered the Masters of Toxicology program. Where he worked on the effects of Valium and its metabolism while taking Tagamet for the condition of anxiety induced ulcers. He later received his MBA from The Sawyer School of Business at Suffolk University specializing in corporate finance, completed the Advanced Management Program at Harvard Business School and the General Management Program at Stanford Business School. He is now finishing in 2019 his PhD dissertation defense in Divinity from Northwestern Seminary. Frank started a chain of independent pharmacies shortly out of school and eventually sold it. He worked in various positions throughout the American Hospital Supply and later the Baxter International organization prior to leaving he was part of the senior management team for the Neuro-surgical business unit.
Frank spent a period of time as an investment banker prior to becoming the President of Kontron Instruments a maker of a class 3 medical device; an Intra-Aortic Balloon and console. He worked with the Food & Drug administration in developing internal policies and practices which would eventually lead to the removing of the consent decree which was placed on the company for poor manufacturing practices prior to his involvement. He returned the company to profitability after a long period of losses. Kontron was eventually sold to a prominent medical device company. As Senior Vice President of North America for Haemonetics Corporation, Frank managed the day to day activities for the North America business activities. During his tenure sales and profits grew double digits for 13 consecutive quarters and the stock of the Company doubled and forward split and grew 40% before he left to run Sandoz Pharma North American Operations. Sandoz eventually merged with Ciba becoming one of the largest Pharma companies in the world, Novartis.
Frank then went on to create one of the largest infusion therapy and Medicare nursing companies in the world, employing more than 40,000 employees and generating over 950 million dollars in revenue. He then created several orthopedic product and services entities. One of which, Orthorehab, was sold for 52 times its original investment within just 30 months culminating in a sale for 52 million dollars. This entity changed the paradigm within the orthopedic surgical office practice environment. The Company provided a turnkey in office solution allowing for durable medical equipment distribution to the surgeon’s patient base.
Today, Frank has founded a state-of-the-art genetics diagnostic laboratory, Genetics Institute of America. The focus of GIA is based on precision medicine. GIA tests for immune therapy and chemo therapy markets along with tumor sequencing, DNA mutations, M-RNA markers and pharmacogenomics.
He currently assists companies who are building, restructuring, transforming and resurrecting their business’s. An example of his client base are, Sympta Holding Corp, Xenetic Biosciences , IPC Medical Corp, Just Fellowship Corp, Environmental Services Inc., Parsons Post House LLC, ClickStream Corporation as well as having a business talk radio show; The Business Architect on the URBN network.
Broward Lic # NR-30211053
Palm Beach Lic # NR-30211442